 NEW YORK--BUSINESS WIRE-- AcelRX--Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased AcelRx Pharmaceuticals, Inc. NASDAQ: ACRX securities between March 17, 2020 and February 12, 2021, both dates inclusive the Class Period. Investors have until August 9, 2021 to apply to the Court to be appointed a 